Products

Primary tabs

Export products to Excel

Displaying 16 - 30 of 32
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Partner: Bayer HealthCare
Development Status: Active Development
Target: Female, Male
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase I
Partner: WHO HRP, CONRAD, NICHD
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable, Subdermal
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase I
Partner: FHI 360
Alternative Name: Oil-based drospirenone (DSRP) microcrystal suspension
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Partner: Bayer HealthCare
Development Status: Limited Market Approval
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Marketed
Alternative Name: Depo-subQ + Uniject
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Marketed
Partner: Pfizer, PATH, USAID
Alternative Name: TU, Aveed
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase III
Alternative Name: TV-46046
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase I
Alternative Name: Triclovera, OSKB -1
Development Status: Limited Market Approval
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Marketed
Export to Excel